Literature DB >> 26397980

Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.

Bruno Filhon1, Boris Lacarra1, Charles Hervouet2, Marie Jaffray1, Pascale Schneider1,3, Jean-Pierre Vannier1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26397980     DOI： 10.1002/pbc.25724

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

Review 1.  Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.

Authors:  Duccio Maria Cordelli; Riccardo Masetti; Daniele Zama; Francesco Toni; Ilaria Castelli; Emilia Ricci; Emilio Franzoni; Andrea Pession
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

2.  Reversible Encepahlopathy Induced by Ifosfamide with Brain Imaging.

Authors:  Daoud Ali Mohamed; Arthur Semedo; Boris Adeyemi; Leila Hessissen; Maria El Kababri; Nazik Allali; Latifa Chat; Siham El Haddad
Journal:  Glob Pediatr Health       Date:  2021-07-14

Review 3.  A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature.

Authors:  Gabriel Chain; Mudit Kalia; Karen Kestenbaum; Lara Pappas; Anna Sechser-Perl; Gadi Abebe Campino; Nibal Zaghloul
Journal:  BMC Pediatr       Date:  2022-02-02       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.